The COVID-19 pandemic continues to be a worldwide threat that tests the capacity of health care systems around the globe. But the potential for cell-based interventions, including those reliant on cord tissue mesenchymal stem cells (MSCs), to make a meaningful difference in the outcomes of patients with severe manifestations of COVID-19 has garnered huge interest from the scientific and medical communities as well as the mainstream press. […]

Many people know someone with osteoarthritis (OA), which affects more than 30 million people in the United States and over[…]